UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Kings and commoners at Copan: Isotopic evidence for origins and movement in the Classic Maya period

Journal of anthropological archaeology, 2010-03, Vol.29 (1), p.15-32

2010

Volltextzugriff (PDF)

Retrodural space: a cadaveric evaluation

Anaesthesia reports, 2024-07, Vol.12 (2), p.e12323

2024

Volltextzugriff (PDF)

The Origins of Maya States

1, 2016

Volltextzugriff (PDF)

4-(Phenylamino)pyrrolopyrimidines: Potent and Selective, ATP Site Directed Inhibitors of the EGF-Receptor Protein Tyrosine Kinase

Journal of medicinal chemistry, 1996-06, Vol.39 (12), p.2285-2292

1996

Volltextzugriff (PDF)

Tyrosine kinase inhibitors in cancer treatment (Part II)

Expert opinion on therapeutic patents, 1998-12, Vol.8 (12), p.1599-1625

Traxler, Peter

1998

Volltextzugriff (PDF)

Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors

Pharmacology & therapeutics (Oxford), 1999-05, Vol.82 (2), p.195-206

1999

Volltextzugriff (PDF)

Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro

Cancer research (Chicago, Ill.), 2004-04, Vol.64 (7), p.2333-2337

2004

Volltextzugriff (PDF)

AEE788: A dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (14), p.4931-4941

2004

Volltextzugriff (PDF)

Protein tyrosine kinase inhibitors in cancer treatment

Expert opinion on therapeutic patents, 1997-06, Vol.7 (6), p.571-588

Traxler, Peter M

1997

Volltextzugriff (PDF)

Tyrosine kinase inhibitors: From rational design to clinical trials

Medicinal research reviews, 2001-11, Vol.21 (6), p.499-512

2001

Volltextzugriff (PDF)

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Molecular cancer therapeutics, 2005-01, Vol.4 (1), p.101-112

2005

Volltextzugriff (PDF)

Protein kinases as targets for anticancer agents: from inhibitors to useful drugs

Pharmacology & therapeutics (Oxford), 2002-02, Vol.93 (2), p.79-98

2002

Volltextzugriff (PDF)

Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma

Cancer research (Chicago, Ill.), 2000-06, Vol.60 (11), p.2926-2935

2000

Volltextzugriff (PDF)

4,5-Dianilinophthalimide: A Protein-Tyrosine Kinase Inhibitor with Selectivity for the Epidermal Growth Factor Receptor Signal Transduction Pathway and Potent in vivo Antitumor Activity

Proceedings of the National Academy of Sciences - PNAS, 1994-03, Vol.91 (6), p.2334-2338

1994

Volltextzugriff (PDF)

The Lady or the Horse: Tristan at the Grail Pentecost

Arthuriana (Dallas, Tex.), 2009-04, Vol.19 (1), p.32-46

TRAXLER, JANINA P.

2009

Volltextzugriff (PDF)

Le Roman de Tristan en Prose vol. v (review)

Arthuriana (Dallas, Tex.), 2009-03, Vol.19 (1), p.82-83

Traxler, Janina P

2009

Volltextzugriff (PDF)

Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor

European journal of medicinal chemistry, 2004, Vol.39 (1), p.11-26

2004

Volltextzugriff (PDF)

ATP site-directed competitive and irreversible inhibitors of protein kinases

Medicinal research reviews, 2000-01, Vol.20 (1), p.28-57

2000

Volltextzugriff (PDF)

Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines

Journal of medicinal chemistry, 1997-10, Vol.40 (22), p.3601-3616

1997

Volltextzugriff (PDF)

New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis

Journal of medicinal chemistry, 2000-06, Vol.43 (12), p.2310-2323

2000

Volltextzugriff (PDF)

Sulfonylbenzoyl-nitrostyrenes: Potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase

Journal of medicinal chemistry, 1991-08, Vol.34 (8), p.2328-2337

1991

Volltextzugriff (PDF)

Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors

The Journal of biological chemistry, 1990-12, Vol.265 (36), p.22255-22261

1990

Volltextzugriff (PDF)

4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity

Clinical cancer research, 1995-08, Vol.1 (8), p.813-821

1995

Volltextzugriff (PDF)

Use of a Pharmacophore Model for the Design of EGFR Tyrosine Kinase Inhibitors: Isoflavones and 3-Phenyl-4(1H)-quinolones

Journal of medicinal chemistry, 1999-03, Vol.42 (6), p.1018-1026

1999

Volltextzugriff (PDF)

Integral Role of the EGF Receptor in HGF-Mediated Hepatocyte Proliferation

Biochemical and biophysical research communications, 2002-01, Vol.290 (1), p.197-203

2002

Volltextzugriff (PDF)

1 – 25 von 490

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(391)
Mit Volltextzugriff
(442)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Kings and commoners at Copan: Isotopic evidence for origins and movement in the Classic Maya period

Retrodural space: a cadaveric evaluation

The Origins of Maya States

4-(Phenylamino)pyrrolopyrimidines: Potent and Selective, ATP Site Directed Inhibitors of the EGF-Receptor Protein Tyrosine Kinase

Tyrosine kinase inhibitors in cancer treatment (Part II)

Strategies toward the Design of Novel and Selective Protein Tyrosine Kinase Inhibitors

Imatinib mesylate is a potent inhibitor of the ABCG2 (BCRP) transporter and reverses resistance to topotecan and SN-38 in vitro

AEE788: A dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity

Protein tyrosine kinase inhibitors in cancer treatment

Tyrosine kinase inhibitors: From rational design to clinical trials

Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition

Protein kinases as targets for anticancer agents: from inhibitors to useful drugs

Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma

4,5-Dianilinophthalimide: A Protein-Tyrosine Kinase Inhibitor with Selectivity for the Epidermal Growth Factor Receptor Signal Transduction Pathway and Potent in vivo Antitumor Activity

The Lady or the Horse: Tristan at the Grail Pentecost

Le Roman de Tristan en Prose vol. v (review)

Salicylanilides as inhibitors of the protein tyrosine kinase epidermal growth factor receptor

ATP site-directed competitive and irreversible inhibitors of protein kinases

Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines

New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven Angiogenesis

Sulfonylbenzoyl-nitrostyrenes: Potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase

Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors

4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activity

Use of a Pharmacophore Model for the Design of EGFR Tyrosine Kinase Inhibitors: Isoflavones and 3-Phenyl-4(1H)-quinolones

Integral Role of the EGF Receptor in HGF-Mediated Hepatocyte Proliferation

Suchergebnisse filtern